Davis Opportunity Fund Class A (RPEAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
38.47
+0.06 (0.16%)
Jun 4, 2025, 3:53 PM EDT
-7.55% (1Y)
| Fund Assets | 507.86M |
| Expense Ratio | 0.93% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | 6.30 |
| Dividend Yield | 15.63% |
| Dividend Growth | 167.95% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 13, 2024 |
| Previous Close | 38.41 |
| YTD Return | 3.09% |
| 1-Year Return | 16.53% |
| 5-Year Return | 103.29% |
| 52-Week Low | 33.21 |
| 52-Week High | 46.93 |
| Beta (5Y) | n/a |
| Holdings | 44 |
| Inception Date | Dec 1, 1994 |
About RPEAX
The Davis Opportunity Fund Class A (RPEAX) seeks to achieve growth of capital. RPEAX seeks to invest primarily in common stock of U.S. companies with small and medium market capitalizations of less than $20 billion.
Fund Family Davis Funds A
Category Large Value
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol RPEAX
Share Class Class A
Index S&P Composite 1500 TR
Performance
RPEAX had a total return of 16.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.62%.
Top 10 Holdings
47.97% of assets| Name | Symbol | Weight |
|---|---|---|
| Quest Diagnostics Incorporated | DGX | 7.11% |
| Capital One Financial Corporation | COF | 6.98% |
| Markel Group Inc. | MKL | 5.68% |
| CVS Health Corporation | CVS | 4.92% |
| Viatris Inc. | VTRS | 4.49% |
| The Cigna Group | CI | 4.25% |
| Teck Resources Limited | TECK | 3.69% |
| TOURMALINE OIL CORP COMMON STOCK | TOU | 3.68% |
| Humana Inc. | HUM | 3.66% |
| U.S. Bancorp | USB | 3.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 13, 2024 | $6.302 | Dec 16, 2024 |
| Dec 8, 2023 | $2.3519 | Dec 11, 2023 |
| Dec 9, 2022 | $2.8159 | Dec 12, 2022 |
| Dec 9, 2021 | $3.8687 | Dec 10, 2021 |
| Dec 10, 2020 | $1.057 | Dec 11, 2020 |
| Dec 12, 2019 | $1.752 | Dec 13, 2019 |